• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    XWELL Announces Definitive Agreement to Divest XpresSpa and XpresTest Businesses

    7/7/26 9:15:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary
    Get the next $XWEL alert in real time by email
    • Transformative transaction intended to maximize stockholder value
    • Repositions the Company to pursue a new strategic direction in the national security sector
    • Strengthens the Company’s ability to deploy capital toward growth initiatives



    NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a provider of wellness and biosecurity solutions, and Face Haus, LLC ("Face Haus"), a leading skincare service and product business, today announced that the Company has entered into a definitive agreement with an affiliate of Face Haus, Express Wellness Group, LLC, under which XWELL will divest its XpresSpa Holdings, LLC and XpresTest, Inc. businesses for $13 million, subject to certain closing adjustments.

    The divestiture is intended to maximize value for XWELL’s stockholders and help facilitate a transformative strategic restructuring of XWELL. As the Company seeks to pursue a new direction in the national security sector, proceeds from the divestiture are expected to strengthen the Company’s ability to deploy capital toward growth initiatives and support the Company’s long-term success.

    XWELL’s health and wellness operations at retail locations outside of airports are not included in the divestiture. In conjunction with the transaction, XWELL will continue its efforts to streamline operations, reduce operating expenses, and allocate capital toward initiatives aligned with its evolving business strategy.

    Bruce Bernstein, Chairman of the Board of the Company, stated, "This transaction represents an important milestone in the Company’s strategic evolution. By simplifying our portfolio and strengthening our balance sheet, we believe XWELL will be better positioned to pivot and pursue opportunities in the national security sector while maintaining financial discipline and creating long-term value for our stockholders."

    The transaction, which is expected to close later in 2026, is subject to XWELL stockholder approval and the satisfaction of other closing conditions.

    About XWELL, Inc.   

    XWELL, Inc. (NASDAQ:XWEL) is a global wellness company on a mission to liberate science-proven wellness for all. Through a portfolio of brands that include XpresSpa®, Naples Wax Center®, and XpresCheck®, XWELL delivers accessible, real-world wellness across travel, retail, and clinical settings. For more information on XWELL’s offerings, visit www.XWELL.com.

    About Face Haus

    Face Haus is a leading and innovative skincare service company that operates retail locations in Texas and California and provides wellness offerings in several airport lounges across the U.S. The company also distributes and sells a full assortment of high quality skincare products under the Face Haus brand. For more information on Face Haus, visit www.thefacehaus.com.

    Participants in the Solicitation

    The Company and its directors and executive officers, and other members of management and employees, may be deemed to be participants in the solicitation of proxies from the Company’s stockholders in connection with the proposed transaction. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation, and a description of their direct and indirect interests, by security holdings or otherwise, will be set forth in the proxy statement and other relevant materials to be filed with the SEC when they become available.

    Additional Information and Where to Find It

    This communication is being made in connection with the proposed transaction. In connection with the proposed transaction, the Company intends to file relevant materials with the Securities and Exchange Commission (the "SEC"), including a proxy statement. This communication is not a substitute for the proxy statement or any other document that the Company may file with the SEC. STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Stockholders will be able to obtain the proxy statement and other documents (when available) free of charge at the SEC’s website, www.sec.gov, or free of charge from the Company at www.XWELL.com.

    Forward-Looking Statements

    This press release may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: (i) the receipt of third-party approvals and the satisfaction of other closing conditions in the anticipated timeframe or at all, including the possibility that the proposed transaction does not close; (ii) risks related to the ability to realize the anticipated strategic, financial or other benefits of the proposed transaction, including the possibility that unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies could impact the value, timing or advisability of the proposed transaction; and (iii) impacts to business operations of the separation of business lines in scope for the divestiture. Forward-looking statements relating to expectations about future results or events are based upon information available to XWELL as of the date of this press release, and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in the Company’s Annual Report on Form 10-K, as amended, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and other Securities and Exchange Commission filings. All subsequent written and oral forward-looking statements concerning XWELL, or other matters and attributable to XWELL or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XWELL does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.

    Media Contact:

    eernst@xwel.com



    Primary Logo

    Get the next $XWEL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XWEL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $XWEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Weinstein Robert was granted 100,000 shares, increasing direct ownership by 87% to 215,231 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    3/2/26 7:45:36 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Director Lebowitz Michael was granted 100,000 shares, increasing direct ownership by 90% to 211,122 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    3/2/26 7:43:54 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    President and CEO Ernst Ezra was granted 100,000 shares, increasing direct ownership by 99% to 201,130 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    3/2/26 7:43:16 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    XWELL Announces Definitive Agreement to Divest XpresSpa and XpresTest Businesses

    Transformative transaction intended to maximize stockholder valueRepositions the Company to pursue a new strategic direction in the national security sector Strengthens the Company’s ability to deploy capital toward growth initiatives NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a provider of wellness and biosecurity solutions, and Face Haus, LLC ("Face Haus"), a leading skincare service and product business, today announced that the Company has entered into a definitive agreement with an affiliate of Face Haus, Express Wellness Group, LLC, under which XWELL will divest its XpresSpa Holdings, LLC and XpresTest, Inc. businesses for $13 m

    7/7/26 9:15:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Reports Fiscal 2025 Results

    NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced financial results for the year ended December 31, 2025. Recent Operating Highlights XWELL delivered 2025 revenue of approximately $29.2 million.Total operating expenses decreased by approximately 10% versus the comparable prior year period.Cost of sales decreased approximately 13% versus 2024.  General and administrative expenses decreased approximately 20% year-over-year.In December 2025, the Company opened a new wellness retail location in New York City's Pennsylvania Station.In February 2026, XWELL entered int

    4/1/26 4:30:00 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    AI Biotech, APAC Expansion, and Balance Sheet Rebuilds Set the Morning Tone

    DENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets. From micro-cap transformation stories to cash-rich TechBio platforms, this morning's tape highlights companies positioning for scale in 2026 and beyond. Totaligent Targets APAC Biologics and Medical Tourism Totaligent (OTCID: TGNT) announced the execution of a binding Letter of Intent (LOI) with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a joint venture integrating Totaligent's recently announced Aetherium Medical platform. The agreement e

    2/25/26 9:38:05 AM ET
    $NXPL
    $RXRX
    $XWEL
    Telecommunications Equipment
    Telecommunications
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $XWEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wizenberg Gaelle Sandra bought $1,987 worth of shares (1,201 units at $1.65), increasing direct ownership by 402% to 1,500 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    9/13/24 5:41:59 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Director Wizenberg Gaelle Sandra bought $551 worth of shares (299 units at $1.84) (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    7/22/24 8:47:43 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    SEC Filings

    View All

    XWELL Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - XWELL, Inc. (0001410428) (Filer)

    7/9/26 4:05:24 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    SEC Form 10-Q filed by XWELL Inc.

    10-Q - XWELL, Inc. (0001410428) (Filer)

    5/20/26 4:05:39 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    SEC Form NT 10-Q filed by XWELL Inc.

    NT 10-Q - XWELL, Inc. (0001410428) (Filer)

    5/15/26 4:05:10 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Leadership Updates

    Live Leadership Updates

    View All

    XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor

    NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced the continued expansion of its global biosecurity strategy, leveraging its traveler-based pathogen surveillance capabilities to support international travel hubs and large-scale mass gathering events worldwide. To support this next phase of growth, XWELL announced today that Cindy Friedman, M.D., former CDC senior advisor and the founding director of CDC's Traveler-based Genomic Surveillance (TGS) program, will serve as a senior advisor to the Company. In this role, Dr. Friedman will provide strategic guidance on t

    1/8/26 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Expands Florida Presence with Grand Opening of Waterford Lakes Wellness Center on September 5

    ORLANDO, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- XWELL (NASDAQ:XWEL) ("XWELL" or the "Company"), a leader in wellness solutions for people on the go, is pleased to announce the grand opening of its newest Florida wellness center at Orlando's Waterford Lakes Town Center on Thursday, September 5. The celebration will feature live demonstrations, skincare consultations, and special participation from the Orlando Magic, which recently named XWELL its official wellness spa. You're Invited: Celebrate with UsGuests are invited to join XWELL for an official ribbon-cutting and a first look at the Orlando area's newest destination for self-care: Date: Thursday, September 5Time: 3:00 PM – 7:00 PM E

    8/28/25 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Launches All-New Website, Offering Seamless Booking and Unified Access to Health, Wellness & Beauty Services

    NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL), a leading provider of wellness solutions for people on the go, today unveiled its newly redesigned website — a digital destination that integrates all of the company's services and offerings, allowing customers to discover, book, and engage through a seamless, user-first experience. Accessible at xwell.com, the updated platform unites XWELL's health, wellness, and beauty brands — Xpres Spa®, Naples Wax Center®, XpresCheck®, and HyperPointe™ — under one cohesive experience. Visitors can now explore locations, connect with spa staff, and book services, all in a few clicks. "This new website is a reflection of where XWEL

    7/29/25 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Financials

    Live finance-specific insights

    View All

    XWELL Reports Second Quarter 2025 Results

    NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced results for the second quarter ended June 30, 2025. From providing critical biosecurity support to building tech-forward wellness spaces in transportation hubs and local communities, XWELL currently is on a growth trajectory. Through its portfolio of in-airport and off-airport brands, the Company is reimagining what it means to access wellness. Operating Highlights Revenue for the 2025 second quarter totaled $7.7 millionCost of sales decreased approximately 5% from the 2024 second quarterGeneral and administrativ

    8/14/25 4:30:31 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL, Inc. to Report Second Quarter 2025 Results on Thursday, August 14, 2025

    NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced that it will report second quarter 2025 financial results on Thursday, August 14, 2025, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m. ET. The Company encourages investors, and interested parties, to listen via webcast, as there is a limited capacity to access the conference call by dialing 1-412-317-6026. The live and later archived webcast can be accessed from the Investor Relations section of the Company's website at https://www.xwell.com. Visitors to the

    8/13/25 4:30:42 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness

    NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a pioneer in science-proven, accessible wellness, today reported results for the first quarter ended March 31, 2025. With a growing portfolio of in-airport and off-airport wellness brands, XWELL continues to redefine what wellness access looks like --connecting high-impact, science-backed care to everyday consumers wherever they are. From leading the nation's biosecurity response to building tech-forward wellness spaces in transportation hubs and neighborhoods alike, XWELL is extending wellness beyond the elite and into real life. Operating Highlights: Reported first quarter 2025 revenue of $

    5/20/25 4:15:18 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by XWELL Inc.

    SC 13D/A - XWELL, Inc. (0001410428) (Subject)

    8/13/24 5:18:44 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by XWELL Inc.

    SC 13G - XWELL, Inc. (0001410428) (Subject)

    8/9/24 4:05:23 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by XWELL Inc.

    SC 13D/A - XWELL, Inc. (0001410428) (Subject)

    7/22/24 6:11:01 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary